Literature DB >> 10792228

In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.

A K Gupta1, Y Kohli, A Li, J Faergemann, R C Summerbell.   

Abstract

Fifty-five strains, either authentic or ex-type, of seven Malassezia species were investigated for in vitro susceptibility to various concentrations (0.03-64.0 microg/mL) of three azole drugs, ketoconazole, voriconazole and itraconazole, as well as the allylamine terbinafine, using the agar dilution method. All strains of the seven Malassezia species were susceptible to the three azole drugs at low concentrations. M. furfur, M. sympodialis, M. slooffiae, M. pachydermatis, M. globosa, M. obtusa and M. restricta were most sensitive to ketoconazole and itraconazole, with minimum inhibitory concentrations (MICs) ranging from < or = 0.03 to 0.125 microg/mL. The recently introduced antifungal, voriconazole, was also very effective, with MIC80 values < or = 0.03 microg/mL for 80% of strains. MICs of terbinafine against the seven Malassezia species ranged from </= 0.03 to 64.0 microg/mL. There were variations in susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Strains of M. furfur, M. globosa and M. obtusa were more tolerant to terbinafine than the remaining Malassezia species; M. sympodialis was highly susceptible. M. furfur strains tested with terbinafine ranged from highly susceptible to relatively resistant. Correct identification of Malassezia species could facilitate selection of appropriate antifungal therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792228     DOI: 10.1046/j.1365-2133.2000.03294.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  24 in total

1.  A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp.

Authors:  Takashi Sugita; Mami Tajima; Hisae Tsubuku; Ryoji Tsuboi; Akemi Nishikawa
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Malassezia: a case of coexisting pityriasis versicolor and Malassezia folliculitis.

Authors:  Ellie Choi; Chris Lixian Tan; Derrick Aw
Journal:  Singapore Med J       Date:  2018-06-21       Impact factor: 1.858

3.  Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species.

Authors:  Takashi Sugita; Mami Tajima; Tomonobu Ito; Masuyoshi Saito; Ryoji Tsuboi; Akemi Nishikawa
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient.

Authors:  Annabelle de St Maurice; Haydar Frangoul; Alice Coogan; John V Williams
Journal:  Pediatr Transplant       Date:  2014-09-03

5.  A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.

Authors:  S Rincón; M C Cepero de García; A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 6.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

7.  Antifungal Susceptibility Testing of Malassezia spp. with an Optimized Colorimetric Broth Microdilution Method.

Authors:  Cheryl Leong; Antonino Buttafuoco; Martin Glatz; Philipp P Bosshard
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

8.  In vitro antifungal susceptibility of Malassezia pachydermatis strains isolated from dogs with chronic and acute otitis externa.

Authors:  E Chiavassa; P Tizzani; A Peano
Journal:  Mycopathologia       Date:  2014-07-17       Impact factor: 2.574

Review 9.  Atopic dermatitis and fungi.

Authors:  Jan Faergemann
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.

Authors:  Margarita Garau; Manolo Pereiro; Amalia del Palacio
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.